Head-to-head · WeighScore
Evolve Telemed vs Spry
The verdict
Evolve Telemed takes it — 58.1/100 to 56.8/100, but only just.
Evolve Telemed grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Evolve Telemed is a hormone- and peptide-optimization telehealth practice for men and women, spanning TRT, weight management, sexual wellness, hair restoration, menopause/BHRT and thyroid. Spry is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Evolve Telemed | Spry |
|---|---|---|
| WeighScore | 58.1/100 | 56.8/100 |
| Grade | C | C |
| Scorecard rank | #379 | #408 |
| Semaglutide | Not disclosed | $199/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $299/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #379 · C
Strengths
- Established hormone- and peptide-optimization brand with board-certified specialists and a physician-plus-care-specialist support model
- Compounded GLP-1 (semaglutide) weight care offered alongside TRT, menopause/BHRT, thyroid and sexual-wellness programs in one practice
- Coordinated couples care plans plus dedicated men's and women's tracks
- Free consultation to start, with published press, blog and FAQ resources
Where it loses points
- No GLP-1 pricing published — cost is only revealed after a consultation, so you can't compare value upfront
- Doesn't list the states it serves or name its compounding pharmacies
- Weight loss is one of many verticals, not a dedicated GLP-1-first program
- Tirzepatide availability isn't confirmed on the site; only compounded semaglutide is referenced
- Not shown on our price-ranked /best lists because no pricing is disclosed
Graded #408 · C
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
Where it loses points
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.